Subclinical atherosclerosis in patients with hidradenitis suppurativa treated with TNF inhibitors

BACKGROUND: Hidradenitis suppurativa (HS) is an independent risk factor for the development of subclinical atherosclerosis. Tumour necrosis factor (TNF) inhibitors are effective for the treatment of recalcitrant moderate‐to‐severe HS. However, the effect of treatment with TNF inhibitors on subclinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Oba, Muazzez Cigdem, Askin, Ozge, Gunver, Mehmet Guven, Kocaarslan, Gokce, Alis, Deniz Can, Engin, Burhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155849/
https://www.ncbi.nlm.nih.gov/pubmed/36973990
http://dx.doi.org/10.1111/srt.13302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155849/
https://www.ncbi.nlm.nih.gov/pubmed/36973990
http://dx.doi.org/10.1111/srt.13302

Ejemplares similares